8-K

Company

Xeris Biopharma Holdings, Inc.

Filed

March 6, 2025

Period of Report

March 6, 2025

Accession Number

0001867096-25-000034

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →